Updates are available Correction dated 2021-10-20
Click to view Correction: https://doi.org/10.1038/s41586-021-04123-9
-
Authors
Kaptein, Suzanne J. F. https://orcid.org/0000-0002-7935-0219
Goethals, Olivia
Kiemel, Dominik
Marchand, Arnaud
Kesteleyn, Bart
Bonfanti, Jean-François https://orcid.org/0000-0002-2107-8857
Bardiot, Dorothée
Stoops, Bart
Jonckers, Tim H. M.
Dallmeier, Kai https://orcid.org/0000-0002-8117-9166
Geluykens, Peggy
Thys, Kim
Crabbe, Marjolein
Chatel-Chaix, Laurent https://orcid.org/0000-0002-7390-8250
Münster, Max
Querat, Gilles
Touret, Franck https://orcid.org/0000-0002-4734-2249
de Lamballerie, Xavier
Raboisson, Pierre
Simmen, Kenny
Chaltin, Patrick
Bartenschlager, Ralf https://orcid.org/0000-0001-5601-9307
Van Loock, Marnix https://orcid.org/0000-0003-4151-4588
Neyts, Johan https://orcid.org/0000-0002-0033-7514
- License Information
-
More Information
Article History
Received: 30 June 2020
Accepted: 1 September 2021
First Online: 6 October 2021
Change Date: 20 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-021-04123-9
Competing interests
: S.J.F.K., O.G., A.M., B.K., J.-F.B., D.B., B.S., T.H.M.J., K.D., P.R., K.S., P.C., M.V.L. and J.N. have filed a patent application claiming the discovery of this class of antiviral molecules as DENV replication inhibitors (WO/2017/167951). The other authors declare no competing interests.
